Teladoc Health, Inc. provided earnings guidance for the second quarter and full year of 2024. For the second quarter, the company expects revenue of $635 million to $660 million, net loss per share of $0.45 to $0.35.

For the Full year, the company expects revenue of $2,635 million to $2,735 million, net loss per share of $1,10 to $0.80.